SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is generating buzz following news of its additive-manufactured fuel tank development for the Vigoride-7 orbital vehicle, slated for a SpaceX mission, alongside its role in U.S. Space Force initiatives. The community is sharply divided, with some anticipating a significant short squeeze fueled by an exceptionally low share float in the hot space sector, while others express caution due to the company's past reverse splits and dilution. This volatility is amplified by its connections to major players like SpaceX, NASA, and projects like the "Golden Dome."

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending following the finalization of its Ask Sage acquisition, bolstering its secure generative AI offerings for defense and regulated sectors. The market is also digesting news of significant debt reduction, involving a share conversion, with community sentiment split between optimism for future government contracts and concerns over potential dilution from expanded authorized shares. Many see the company as a key player in critical AI infrastructure, often drawing comparisons to Palantir, while others remain cautious given past stock volatility.

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Zenas Biopharma Inc.

Zenas BioPharma (ZBIO) is generating significant discussion after its Phase 3 INDIGO trial results for obexelimab, which, despite meeting its primary endpoint with a 56% reduction in disease flares, led to a sharp stock decline. The community is actively debating the disconnect between the 'positive' data and the sell-off, with many citing unmet efficacy expectations and the company's confirmed ineligibility for a $75 million royalty milestone payment as key drivers. This has created a polarized outlook, with some investors calling it 'classic biotech' volatility and others viewing the considerable dip as a prime buying opportunity.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is actively discussed due to widespread speculation about its crucial involvement in a recent US military operation that led to the capture of Venezuela's leader, solidifying its perception as an indispensable asset for national security. This event has ignited bullish sentiment among investors who foresee a significant rally driven by the real-world application of its AI software, while skeptics point to high valuations and the speculative nature of the news.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending due to significant geopolitical developments in Venezuela, where recent U.S. actions have spurred conversations about potential access to the nation's vast oil reserves. The community is actively discussing Chevron's unique position as the only U.S. major still operating there, viewing it as a strategic advantage for future production. However, some market participants remain cautious about the long-term impact on global oil supply and potential revenue implications.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending due to widespread community discussion surrounding potential US involvement in Venezuela and the prospect of American oil companies, including XOM, re-entering the nation's vast oil reserves. Investors are actively debating whether this geopolitical development signals a major breakout and significant profits for the energy giant or if it will lead to an oversupply that could pressure crude prices.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending with significant anticipation surrounding an imminent Department of Energy announcement regarding plutonium awards, which is seen as a crucial catalyst to de-risk its fuel supply for advanced nuclear reactors. Enthusiasts view this as a "golden ticket" poised to accelerate deployment and meet the escalating power demands of AI data centers, despite some market skepticism over its current pre-revenue status and high valuation.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending amid intense debate, as the stock grapples with ongoing share sales from a major holder and concerns over a recent vote to double authorized shares. Despite significant price action, bullish investors are highlighting its unique NRC-approved Small Modular Reactor (SMR) technology as crucial for emerging AI data center energy needs and anticipating major contract announcements. Meanwhile, skeptics are focused on dilution and its pre-revenue status within the evolving nuclear energy sector.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as the community eagerly awaits a "game-changer" partnership announcement for its new Federal AI unit, with widespread speculation around a strategic collaboration with Carahsoft or a prominent defense contractor. Despite recent price declines, many perceive the stock as significantly undervalued given its unique position in government and sovereign AI data training, with hopes for a short squeeze if positive news materializes.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is experiencing notable volatility and a sharp reversal from recent highs, fueling an intense debate among investors over its current valuation. Bulls champion the company's AI-driven ad-tech platform and exceptional profitability as drivers for future growth, while a vocal bear contingent contends the stock is significantly overvalued and due for a further correction. The market is actively weighing Applovin's strong operating leverage and position in the evolving mobile advertising landscape against concerns about its premium pricing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLO (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO (plozasiran), a small interfering RNA (siRNA) medicine...

Corient Private Wealth LLC Takes Position in Arrowhead Pharmaceuticals, Inc. $ARWR

Corient Private Wealth LLC purchased a new position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing...

Insider Selling: Arrowhead Pharmaceuticals (NASDAQ:ARWR) Director Sells 7,530 Shares of Stock

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report) Director Mauro Ferrari sold 7,530 shares of the business's stock in a transaction dated Friday, December 26th. The shares were sold at...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Director Sells $527,100.00 in Stock

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report) Director Mauro Ferrari sold 7,530 shares of the stock in a transaction that occurred on Friday, December 26th. The stock was sold at an...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) CEO Sells $3,575,818.38 in Stock

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report) CEO Christopher Richard Anzalone sold 51,726 shares of the firm's stock in a transaction on Monday, December 29th. The stock was sold...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 3.9% - Time to Sell?

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 3.9% - Should You Sell...

HBK Sorce Advisory LLC Invests $2.82 Million in Arrowhead Pharmaceuticals, Inc. $ARWR

HBK Sorce Advisory LLC acquired a new position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) during the third quarter, according to the company in its most recent disclosure with the...

Exchange Traded Concepts LLC Sells 15,265 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR

Exchange Traded Concepts LLC lessened its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) by 33.0% during the third quarter, according to its most recent 13F filing with the...

Texas Permanent School Fund Corp Buys Shares of 19,104 Arrowhead Pharmaceuticals, Inc. $ARWR

Texas Permanent School Fund Corp bought a new position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) during the 2nd quarter, according to its most recent disclosure with the...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Rating of "Moderate Buy" from Analysts

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the stock...

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

ARWR
Arrowhead Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ARWR News

ARWRArrowhead Pharmaceuticals Inc.